Media Room



Latest News Releases
Nov 9, 2018

Nektar Therapeutics (Nasdaq: NKTR) announced today a presentation of new clinical and preclinical data for its I-O pipeline at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting....

Nov 7, 2018

Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the third quarter ended September 30, 2018. Cash and investments in marketable securities at September 30, 2018 were...

Nov 6, 2018

Nektar Therapeutics (NASDAQ:NKTR) announced that it has entered into an oncology clinical collaboration with Pfizer Inc. (NYSE:PFE) to evaluate several combination regimens in multiple cancer...

More »

Multimedia Libraries
Media Contacts
Dan Budwick
Pure Communications, Inc.

More »

Follow Us on LinkedIn
Follow Us on Twitter

print email
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide